Mouth Ulcer Treatment Market Share, Size, Trends, Industry Analysis Report, By Formulation (Sprays, Mouthwash, Gels, Lozenges), By Drug Class, By Region, And Segment Forecasts, 2024 - 2032
- Published Date:Jan-2024
- Pages: 114
- Format: PDF
- Report ID: PM4047
- Base Year: 2023
- Historical Data: 2019-2022
Report Outlook
The global mouth ulcer treatment market was valued at USD 1.39 billion in 2023 and is expected to grow at a CAGR of 4.10% during the forecast period.
The mouth ulcer treatment market report details key market dynamics to help industry players align their business strategies with current and future trends. It examines technological advances and breakthroughs in the industry and their impact on the market presence. Furthermore, a detailed regional analysis of the industry at the local, national, and global levels has been provided.
Market growth is set to be propelled by heightened consciousness surrounding oral hygiene and the mounting geriatric demographic. Ulcers, characterized as distressing sores and injuries manifesting on the mucous membrane within the mouth, have garnered increased attention. This is underpinned by the escalating utilization of synthetic compounds in oral care items like toothpaste, coupled with a notable inclination towards unhealthy lifestyles marked by excessive consumption of junk food and tobacco. These factors collectively stand as significant drivers fueling market expansion. Furthermore, the escalating prevalence of dental and oral ailments is foreseen to amplify the demand for treatment solutions.
To Understand More About this Research: Request a Free Sample Report
The global geriatric populace is set to be a driving force behind mouth ulcer treatment market growth during the forecast period. The heightened vulnerability of this demographic underpins this projection due to a gradual decline in immunity that accompanies aging. According to statistics presented in the World Population Prospects 2022 report, the proportion of individuals aged 65 and older within the global population is poised to surge from 10% in 2022 to 16% by 2050. Additionally, between 2020 and 2050, the population count of those aged 80 years and above is projected to undergo a three-fold increase, soaring from 143 million to 426 million.
A considerably relaxed attitude towards ulcers among individuals could potentially have an adverse effect on the market demand for associated treatment products. A lack of understanding prevails regarding the criticality of early treatment for mouth ulcers, which could potentially escalate into cancer if left untreated. However, healthcare professionals are diligently undertaking proactive measures and tests to disseminate awareness and mitigate the detrimental repercussions stemming from ulcers. This ongoing trend is poised to influence the market's trajectory moving forward significantly.
The expansion of the market is impeded by the unfavorable outcomes linked to the utilization of oral ulcer treatment solutions like steroid-based mouthwash or tablets. For example, hydrocortisone buccal tablets, categorized as corticosteroids, are employed to alleviate ulcer-related discomfort. Notably, the administration of hydrocortisone can result in prevalent adverse effects, including headaches, diarrhea, irregular heart rhythms, indigestion, and sensations of dizziness. The Medicines and Health Products Regulatory Agency (MHRA) underscores that continuous usage of topical corticosteroids can trigger withdrawal responses upon discontinuation.
Growth Drivers
- Increasing oral issues due to chemical exposure, raising awareness.
Rising prevalence of oral and dental issues stemming from the intake of synthetic chemicals in both dietary items and dental care products. Additionally, negligence in identifying and addressing dental concerns during their initial phases could potentially escalate into cancer. Consequently, healthcare experts are spearheading campaigns and examinations to disseminate knowledge concerning the detrimental consequences of mouth ulcers. Entities such as the Maryland Department of Health, which designates April as Oral Cancer Awareness Month, contribute to awareness-raising efforts and advocate for individuals to undergo screening for this specific form of cancer.
Nicotine-based products have the potential to impede a patient's recovery, extending the required treatment duration. Furthermore, mouth ulcers represent a frequent consequence of tobacco consumption and smoking cessation, impacting nearly two out of every five individuals who quit smoking. According to WHO, approximately 22.30% of the global population engaged in tobacco product consumption, and more than 80% of tobacco users globally reside in low- and middle-income nations.
Given that tobacco usage can trigger the development of mouth ulcers, the demand for treatment solutions is consequently heightened. According to the NCBI, ulcers are a prevalent condition encountered in outpatient settings, with over 25% of the global population experiencing recurrent aphthous ulcers. Moreover, the escalating prevalence of oral cancers is poised to act as a driving factor fostering market growth.
Report Segmentation
The market is primarily segmented based on formulation, drug class, and region.
|
By Formulation |
By Drug Class |
By Region |
|
|
|
To Understand the Scope of this Report: Speak to Analyst
By Formulation Analysis
- The gels segment dominated the market in 2022.
The gels segment held the largest share. This dominance is attributed to the segment's swift healing formulations, widespread accessibility, and rapid effectiveness in combating inflammation and swelling. Moreover, these gels offer anesthetic attributes, temporarily alleviating the intense discomfort associated with sores. With an array of flavors and formats catering to both adult and pediatric usage, these gels prove to be a versatile solution.
The sprays segment is expected to have faster growth in the market. This growth is primarily due to its minimal incidence of side effects, wide availability, and expedited healing capabilities for sores. The convenience of regular usage for mitigating detrimental consequences further underscores its appeal. Notably, these formulations are favored by adults due to their lower likelihood of causing adverse reactions in comparison to alternative options, ensuring sustained safeguarding benefits.
By Drug Class Analysis
- The analgesics & corticosteroids segment held a lucrative share in 2022.
The analgesics and corticosteroids segment garnered the largest share and is expected to grow at the fastest rate. This prominence can be attributed to the elevated prescription prevalence of these products as pain-relieving agents within the global sphere. Specifically, their utilization as pain alleviators in the management of dental sores underscores their significance.
Corticosteroids exhibit anti-inflammatory attributes that effectively mitigate inflammation resulting from infections. Furthermore, these substances engage with intracellular receptors, inducing modifications in gene expression, ultimately impeding the activity of microorganisms. Globally, analgesics and corticosteroids emerge as the most frequently recommended pharmaceuticals by healthcare practitioners. Renowned for their dependability in addressing diverse oral concerns, these drugs are poised to propel the segment toward substantial growth opportunities.
Regional Insight
- North America registered the largest revenue share in the forecast time frame.
North America garnered the largest revenue share for the market. The United States has witnessed a noteworthy surge in the prevalence of dental issues among its populace. This trend is largely attributed to factors including an unhealthy dietary pattern, tobacco dependency, heightened stress levels, traumatic incidents, and modifications in local immune responses.
As per the United States Surgeon General's report, nearly 25% of the population experiences re-current canker sores. The region's growth trajectory is further propelled by the presence of favorable governmental policies and the initiatives undertaken by entities like the U.S. Department of Health and Human Services, committed to elevating oral health standards across the nation.
Asia Pacific is expected to grow at a rapid pace. The region is poised for dynamic expansion. This projection is buoyed by the escalating awareness surrounding oral hygiene and the endorsement of initiatives by governmental bodies. Leveraging its substantial population base and progressively enhancing healthcare infrastructure, the region is poised to achieve the most promising growth rate. Notably, the region presents significant untapped opportunities, alongside a mounting acknowledgment and adoption of branded products, which collectively contribute to the robust advancement of the regional market.
Additionally, the escalating prevalence of tobacco consumption is foreseen to contribute to a substantial rise in mouth ulcer incidents. According to World in Data, approximately 25% of adults across the globe smoke on a daily basis. This highlights a concerning trend of widespread smoking habits. Furthermore, the region experiences approximately 2.3 million annual fatalities attributed to the detrimental consequences of smoking. The heightened vulnerability to mouth ulcers resulting from smoking is projected to impart a notable impetus to the region's growth trajectory.
Competitive Insight
The mouth ulcer treatment market is fragmented and is anticipated to witness competition due to several players' presence. Major service providers in the market are constantly upgrading their technologies to stay ahead of the competition and to ensure efficiency, integrity, and safety. These players focus on partnership, product upgrades, and collaboration to gain a competitive edge over their peers and capture a significant market share.
Some of the major players operating in the global market include:
- 3M
- Blistex
- Bristol Myers
- Church & Dwight
- Colgate-Palmolive
- GlaxoSmithKline
- Pfizer
Recent Developments
- In August 2022, ICPA Health Products introduced its latest innovation, the Trioplast anti-ulcer dental paste. At the core of this paste lies triamcinolone acetonide, a primary chemical component. This ingredient effectively mitigates or lessens mouth inflammation and irritation by minimizing the body's reaction to allergens.
- In September 2022, Mucocort collaborated with Aurena Laboratories to facilitate the manufacturing of a pain relief patch designed to cater to individuals afflicted with aphthous stomatitis, commonly referred to as mouth ulcers. This patch, categorized as an MDR class II product, expedites the inherent healing process of aphthous ulcers while concurrently alleviating pain.
Mouth Ulcer Treatment Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 1.45 billion |
|
Revenue Forecast in 2032 |
USD 2.00 billion |
|
CAGR |
4.10% from 2024 - 2032 |
|
Base year |
2023 |
|
Historical data |
2019 - 2022 |
|
Forecast period |
2024 - 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Segments Covered |
By Formulation, By Drug Class, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation |
Want to check out the mouth ulcer treatment market report before buying it? Then, our sample report has got you covered. It includes key market data points, ranging from trend analyses to industry estimates and forecasts. See for yourself by downloading the sample report.
Browse Our Top Selling Reports
Adzuki Beans Market Size, Share 2024 Research Report
Non-Potato Veggie Chips Market Size, Share 2024 Research Report
Healthcare Data Integration Market Size, Share 2024 Research Report
Milking Robots Market Size, Share 2024 Research Report
© 2024 Polaris Market Research and Consulting. All rights reserved
